Business Analyst (IT) - Hibrido

LI-Hybrid
Business Analyst DDIT OPS ITOT Aseptics & CGT
Novartis is unable to offer relocation support for this role: please only apply if this location is accessible for you.
The IT Sr. Business Analyst - CDMO will report to the ITOT Head, Morris Plains, and act as the primary ITOT operational and strategic business partner for the Red Apple CDMO collaboration, combining operational execution, initiative delivery, and senior-level governance. The role ensures stable operations, effective escalation management, and strong cross‑functional alignment between Novartis, Red Apple, LDC, and external partners.
Lead and support active CDMO initiatives such as TranSCend, including technical readiness, business testing readiness, change requests, and ongoing progress tracking.
Drive strategic alignment with LDC on timelines, prioritization, and sequencing of Red Apple fixes and enhancements.
Own Red Apple operational activities including data collaboration changes, schedule synchronization, technical backlog and other production‑critical integrations.
Serve as the primary business partner toward Red Apple, leading Tier 2 and Tier 3 governance calls, agenda alignment, and preparation of governance materials.
Maintain constant risk awareness and escalation readiness, leveraging deep knowledge of Red Apple programs and dependencies.
Support legal and contractual topics related to Red Apple, including review and preparation of SOWs and coordination with site stakeholders.
Ensure strong collaboration across IT, business, CDMO stakeholders, and external vendors to minimize business risk and delivery impact.
Bachelor’s degree in a STEM discipline required.

• Manufacturing systems experience (MES, LIMS, ERP) with knowledge of SAP S4HANA, architecture and SAP workflows.
• Strong experience in IT operations, business partnering, and complex cross‑company programs.
• Experience working with external partners, vendors, and regulated environments, with proven ability to manage senior stakeholder governance and escalations.
• Business Acumen